MDUFMA Technical Corrections Clear Congress; House Tackles FDA Approps
This article was originally published in The Gray Sheet
Executive Summary
FDA will submit to Congress a plan for forgiveness of the shortfall in medical device review funding accrued since the initiation of MDUFMA, Acting Commissioner Lester Crawford told the House Appropriations Committee/Agriculture Subcommittee on March 11
You may also be interested in...
Senate Aide Advises FDA Dialogue, Not Legislation, To Obtain User Fee Relief
Manufacturers seeking to revise CDRH performance goals and user fee collection targets are unlikely to find a suitable vehicle in MDUFMA "trigger-fix" legislation this fall
Senate Aide Advises FDA Dialogue, Not Legislation, To Obtain User Fee Relief
Manufacturers seeking to revise CDRH performance goals and user fee collection targets are unlikely to find a suitable vehicle in MDUFMA "trigger-fix" legislation this fall
Small Manufacturer User Fee Discounts Draw 232 Applicants In Early FY 2004
The number of medical device firms requesting small business determinations from FDA in the first quarter of FY 2004 surpassed the FY 2003 total by more than 70%